| Literature DB >> 31864023 |
Frank Pega1, Susan L Norris2, Claudine Backes3, Lisa A Bero4, Alexis Descatha5, Diana Gagliardi6, Lode Godderis7, Tom Loney8, Alberto Modenese9, Rebecca L Morgan10, Daniela Pachito11, Marilia B S Paulo12, Paul T J Scheepers13, Vivi Schlünssen14, Daria Sgargi15, Ellen K Silbergeld16, Kathrine Sørensen17, Patrice Sutton18, Thomas Tenkate19, Denise Torreão Corrêa da Silva20, Yuka Ujita21, Emilie van Deventer3, Tracey J Woodruff18, Daniele Mandrioli15.
Abstract
BACKGROUND: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing joint estimates of the work-related burden of disease and injury (WHO/ILO Joint Estimates). For this, systematic reviews of studies estimating the prevalence of exposure to selected occupational risk factors will be conducted to provide input data for estimations of the number of exposed workers. A critical part of systematic review methods is to assess risk of bias (RoB) of individual studies. In this article, we present and describe the development of such a tool, called the Risk of Bias in Studies estimating Prevalence of Exposure to Occupational risk factors (RoB-SPEO) tool; report results from RoB-SPEO's pilot testing; note RoB-SPEO's limitations; and suggest how the tool might be tested and developed further.Entities:
Mesh:
Year: 2019 PMID: 31864023 PMCID: PMC7479507 DOI: 10.1016/j.envint.2019.105039
Source DB: PubMed Journal: Environ Int ISSN: 0160-4120 Impact factor: 9.621
Fig. 1Steps of the systematic review process.
Definitions of health risk assessment and its steps.
| Term/Step | Definition (taken from |
|---|---|
| Health risk assessment | The “process intended to calculate or estimate the risk to a given target organism, system, or (sub)population, including the identification of attendant uncertainties, following exposure to a particular agent, taking into account the inherent characteristics of the agent of concern as well as the characteristics of the specific target system” (p14) |
| Step 1: Hazard identification | “The identification of the type and nature of adverse effects that an agent has an inherent capacity to cause in an organism, system, or (sub)population” (p13) |
| Step 2: Hazard characterisation | “The qualitative and, wherever possible, quantitative description of the inherent property of an agent or situation having the potential to cause adverse effects. This should, where possible, include a dose–response assessment and its attendant uncertainties” (p13) |
| Step 3: Exposure assessment | “Evaluation of the exposure of an organism, system, or (sub)population to an agent (and its derivatives)” (p12) |
| Step 4: Risk characterisation | “The qualitative and, wherever possible, quantitative determination, including attendant uncertainties, of the probability of occurrence of known and potential adverse effects of an agent in a given organism, system, or (sub)population, under defined exposure conditions” (p14) |
Fig. 2Development of the RoB-SPEO tool.
Stages of receipt and integration of feedback during the development of RoB-SPEO and main innovations introduced.
| Stage | Feedback receipt and integration | Main innovations introduced |
|---|---|---|
| 1 | Three rounds of feedback on RoB-SPEO version (v.) 1 received from seven WHO and ILO experts and 130 individual experts on systematic review methods, occupational health and safety and/or exposure science and integrated in RoB-SPEO v.2 | - Adopted and/or revised tool components from existing tools, including instructions, domains, guiding questions, considerations, ratings and rating criteria |
| 2 | Feedback on RoB-SPEO v.2 received from five external systematic review methodologists, 20 peer reviewers and two journal editors received, integrated in RoB-SPEO v.3, and this tool version published in systematic review protocols (e.g. | - Further refined tool components, especially rating criteria |
| 3 | Three rounds of feedback on RoB-SPEO v.3 received from eight WHO and ILO experts and 30 individual experts in systematic review methods, occupational health, occupational safety and/or exposure science and integrated in RoB-SPEO v.4 | - Revised instructions |
| 4 | One round of feedback on RoB-SPEO v.4 received from pilot testers and integrated in RoB-SPEO v.5 | - Introduced additional domain on bias due to differences in numerator and denominator |
| 5 | Feedback on RoB-SPEO v.5 received from two external systematic review methodologists, four peer reviewers and a journal editor and integrated in RoB-SPEO v.6 presented in this article | - Re-formatted tool for clarity, introducing subheadings to differentiate components |
Existing risk of bias tools identified as relevant for the development of RoB-SPEO.
| Tool | Study types assessed | Why this tool is not applicable | |
|---|---|---|---|
| 1 | ROBINS-I tool ( | Non-randomized studies of the effect of interventions on health outcomes | - Has components applicable exclusively to health outcomes |
| 2 | RoB instrument for non-randomized studies of exposures ( | Non-randomized studies of the effect of exposure to environmental and occupational risk factors on health outcomes | - Has domains applicable exclusively to health outcomes |
| 3 | Navigation Guide RoB tool ( | ||
| 4 | OHAT RoB tool ( | ||
| 5 | Hoy et al. RoB checklist ( | Prevalence studies of health outcomes | - Uses a checklist approach |
| 6 | Munn et al. critical appraisal checklist ( | ||
Domains of risk of bias in RoB-SPEO.
| Domain | Description of bias | Existing tools with such a domain | |
|---|---|---|---|
| 1 | Bias in selection of participants into the study | Bias in selection of participants into the study (commonly called selection bias) is the bias due to systematic differences between the characteristics of the study sample (defined as the sample of individuals participating in the study) and those of the target population (defined as the population for which the authors of the study sought to assess exposure) ( | ROBINS-I, Risk of bias (RoB) instrument for non-randomized studies of exposures, Navigation Guide RoB tool, OHAT RoB tool |
| 2 | Bias due to a lack of blinding of study personnel | Bias due to a lack of blinding of study personnel (commonly called performance bias) is the bias that arises due to a lack of blinding of exposure assessors and other study personnel to relevant participant characteristics (e.g. disease status) that leads to exposure assessment that differs depending on participant characteristics. | Navigation Guide RoB tool, OHAT RoB tool |
| 3 | Bias due to exposure misclassification | Bias due to exposure misclassification is “erroneous [and systematic] classification of an individual, a value, or an attribute into a [exposure] category other than that to which it should be assigned”, leading to under- or over estimation of prevalence of exposure status (or level) ( | ROBINS-I, RoB instrument for non-randomized studies of exposures, Navigation Guide RoB tool, OHAT RoB tool |
| 4 | Bias due to incomplete exposure data | Bias due to incomplete exposure data is the biases that arises from exposure data missing in a way that the exposure assessment is differential by exposure status (or level) in the target population (i.e. not random). | None, but existing tools do have domains on bias due to missing data in general or missing outcome data |
| 5 | Bias due to selective reporting of exposures | Bias due to selective exposure reporting is the systematic difference arising from selective reporting of exposures or exposure categories. | None, but existing tools do have domains on bias due to selective reporting in general or selective reporting of outcomes |
| 6 | Bias due to conflict of interest | Bias due to conflicts of interest is the bias introduced if financial and other interests influence the design, conduct, data collection, analysis and/or reporting of a study ( | Navigation Guide RoB tool |
| 7 | Bias due to differences in numerator and denominator | Bias due to differences in numerator and denominator is the bias that arises when there is a mismatch of definition and/or counting of persons contributing to the numerator and the denominator in the ratio used to estimate prevalence ( | None |
| 8 | Other bias | Other bias is any other bias specific to a particular study rather than applicable to all studies. | ROBINS-I, RoB instrument for non-randomized studies of exposures, Navigation Guide RoB tool, OHAT RoB tool |
Guiding questions by domain.
| Domain | Guiding question | |
|---|---|---|
| 1 | Bias in selection of participants into the study (see | Could the exposure status (or level) assessed (or assigned) in the study sample not represent exposure in the target population? |
| 2 | Bias due to a lack of blinding of study personnel | Could study personnel have known the exposure status (or level) or other characteristics of study participants and, if yes, could this knowledge have influenced how they conducted the exposure assessment? |
| 3 | Bias due to exposure misclassification | Could the methods used for assessing (or assigning) exposure have over- or under-estimated exposure? |
| 4 | Bias due to incomplete exposure data | Could data on exposure status (or level) be incomplete for eligible participants? |
| 5 | Bias due to selective reporting of exposures | Could relevant exposures or exposure categories be selectively not reported? |
| 6 | Bias due to conflict of interest | Could the study and/or one or more study authors have received support from entities with potential interests in the exposure assessed (or assigned)? |
| 7 | Bias due to differences in numerator and denominator | Could the definition and/or counting of persons contributing to the numerator differ from those contributing to the denominator in the ratio used to estimate prevalence? |
| 8 | Other bias | Could the study have other problems that could have introduced bias? |
Fig. 3Instructions (in Italics) and table for recording the assessment.
Interpretation of overall risk of bias ratings in RoB-SPEO.
| Rating (or judgment) | Interpretation |
|---|---|
| Low risk of bias | The study is judged to be at low risk of bias for all domains |
| Probably low risk of bias | The study is judged to be at low or probably low risk of bias for all domains |
| Probably high risk of bias | The study is judged to be at probably high risk of bias in at least one domain, but not at high risk of bias in any domain |
| High risk of bias | The study is judged to be at high risk of bias in at least one domain |
Footnotes: Ratings are adapted and interpretations adopted verbatim from the ROBINS-I tool; see Table 2 in Bero, 2014.
Comparison of existing tools and RoB-SPEO.
| Tool | Types of studies | Evidence streams | Domains | Ratings (or judgments) |
|---|---|---|---|---|
| ROBINS-I ( | Non-randomized studies of the effect of interventions on health | Human data | Pre-intervention: Bias due to confounding Bias in selection of participants into the study Bias in classification of interventions Bias due to deviations from intended interventions Bias due to missing data Bias in measurement of outcomes Bias in selection of the reported result | Low risk of bias Moderate risk of bias Serious risk of bias Critical risk of bias No information |
| Risk of bias (RoB) instrument for non-randomized studies of exposures ( | Studies of the effect of exposure to environmental and occupational risk factors on health outcomes (in the context of health risk assessment: hazard identification; see | Human data | Bias due to confounding Bias in selection of participants into the study Bias in misclassification of exposure Bias due to deviations from intended exposures Bias due to missing data Bias in measurement of outcomes Bias in selection of the reported result | Low risk of bias Moderate risk of bias Serious risk of bias Critical risk of bias No information |
| Navigation Guide RoB tool (human evidence stream) ( | Studies of the effect of exposure to environmental and occupational risk factors on health outcomes (hazard identification) | In vitro, animal, mechanistic and human data | Selection bias a Performance bias b Exposure misclassification bias c Outcome misclassification bias d Confounding e Incomplete outcome data f Selective outcome reporting g Conflict of interest h Other bias i | Low risk Probably low risk Probably high risk High risk Not applicable |
| OHAT RoB tool (cohort, case-control, cross-sectional and case series studies in human evidence stream) ( | Studies of the effect of chemicals on health outcomes (hazard identification) | In vitro, animal, mechanistic and human data | Selection bias j Confounding bias k Performance Attrition/Exclusion bias l Detection bias m Selective reporting bias n Other o | Definitely low risk Probably low risk Probably high risk Definitely high risk |
| RoB-SPEO (see | Prevalence studies of the exposure to occupational risk factors (in the context of health risk assessment: exposure assessment) | Human data | Bias in selection of participants into the study Bias due to a lack of blinding of study personnel Bias due to exposure misclassification Bias due to incomplete exposure data Bias in selection of the reported results Bias due to conflict of interest Bias due to differences in numerator and denominator Other bias | Low risk Probably low risk Probably high risk High risk No information |
Footnotes: Guiding questions are as follows: a Are the study groups at risk of not representing their source populations in a manner that might introduce selection bias? b Was knowledge of the group assignments inadequately prevented (i.e., blinded or masked) during the study, potentially leading to subjective measurement of either exposure or outcome? c Were exposure assessment methods lacking accuracy? d Were outcome assessment methods lacking accuracy? e Was potential confounding inadequately incorporated? f Were incomplete outcome data inadequately addressed? g Does the study report appear to have selective outcome reporting? h Did the study receive any support from a company, study author, or other entity having a financial interest in any of the exposures studied? i Did the study appear to have other problems that could put it at a risk of bias? j Did selection of study participants result in appropriate comparison groups? k Did the study design or analysis account for important confounding and modifying variables? l Were outcome data complete without attrition or exclusion from analysis? m Can we be confident in the exposure characterisation? and Can we be confident in the outcome assessment? n Were all measured outcomes reported? o Were there no other potential threats to internal validity (e.g., statistical methods were appropriate and researchers adhered to the study protocol)?